Clinical Trial Update: A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the combination of Naltrexone SR and Bupropion SR in overweight or obese adults with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Obesity

Drugs mentioned

• Bupropion-SR (bupropion)
• Naltrexone SR (Naltrexone)

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Depression | Phase 2 | Status: COMPLETED